Arteris (AIP) 10% Owner Bayview Legacy Sells Shares

What Happened
Bayview Legacy, LLC — a reported 10% owner of Arteris, Inc. — sold a total of 100,000 Arteris (AIP) shares in open-market transactions on August 3–4, 2026, generating proceeds of approximately $3,051,259. The breakdown: 6,321 shares at $28.79 ($181,959); 42,415 shares at $29.99 ($1,272,051); 25,158 shares at $30.31 ($762,619); 23,506 shares at $31.92 ($750,351); and 2,600 shares at $32.41 ($84,279). These were sales (not purchases) and therefore represent disposition of holdings rather than a bullish purchase signal.

Key Details

• Transaction dates: August 3, 2026 (three tranches) and August 4, 2026 (two tranches). Form 4 filed August 5, 2026 (appears timely).
• Prices and proceeds: see per-trade detail above; total proceeds ≈ $3.05 million. Some reported prices are weighted averages from multiple trades (see ranges below).
• Price ranges (per filing footnotes): trades occurred at prices that ranged roughly from $28.17 up to $32.48 across the multiple executions.
• Plan and reporting: trades were made pursuant to a 10b5-1 trading plan adopted Dec 12, 2025 (Footnote F1). K. Charles Janac, manager of Bayview Legacy, is deemed to have voting/dispositive power (F4) and separately filed a Form 4 reporting the same transactions (F2).
• Shares owned after transaction: not specified in the excerpt provided.
• Filing timeliness: Form 4 was filed Aug 5 for Aug 3–4 trades (filing appears within the normal 2-business-day reporting window).

Context
These sales were executed under a pre-established 10b5-1 plan, which typically means the trades were pre-scheduled rather than ad hoc discretionary sales. As a 10% owner (an institutional/major-holder filing), this is reporting of institutional-level selling rather than an insider executive purchase; the manager (K. Charles Janac) controls the LLC and has filed separately to reflect beneficial ownership. No indications of options exercises, gifts, or tax-withholding transactions were reported in this excerpt.